Publications

Published Books or Book Chapters | Abstracts Presented/Published

  1. Carter JD, Cutolo EP, Behnke RH, Adelman HM. Pulmonary Infiltrates in an Elderly Man. Hospital Practice. 34(8):21-4,1999.
  2. Carter JD, Kanik KS, Valeriano J. Neck Mass in a Rheumatoid Arthritis Patient Taking Etanercept. Journal of Clinical Rheumatology. 6(2):80-1, 2000.
  3. Carter JD, Vasey FB, Valeriano-Marcet J, Kanik KS. “G” Stands for Gout. Arthritis and Rheumatism. 43(6):1418, 2000.
  4. Carter JD, Kanik KS, Vasey FB, Valeriano-Marcet J. Dermatomyositis with Normal Creatine Kinase and Elevated Aldolase Levels (letter). Journal of Rheumatology. 28(10):2366-7, 2001.
  5. Carter JD, Vasey FB, Kanik KS, Valeriano-Marcet. Polymyalgia Rheumatica and Temporal Arteritis with Sacroiliitis and Osteitis Pubis. Journal of Clinical Rheumatology. 7(4):261-4, 2001.
  6. Carter JD, Valeriano-Marcet J, Kanik KS, Vasey FB. ANA Negative Drug Induced Lupus Caused by Lisinopril. Southern Medical Journal. 94(11):1122-3, 2001.
  7. Carter JD, Vasey FB. Psoriatic Arthritis: Genetics, Immunology, and Therapies (Editorial). Journal of Clinical Rheumatology. 7(6):363-5, 2001.
  8. Carter JD, Valeriano J, Vasey FB. Reply to: Dermatomyositis with Normal Creatine Kinase and Elevated Aldolase Levels (letter). Journal of Rheumatology. 29(10):2242-3,2002.
  9. Valeriano J, Carter JD, Vasey FB. Soft Tissue Infections (Review). Rheumatic Disease Clinics of North America. 29(1):77-88, 2003.
  10. McIlwain L, Carter JD, Bin-Sagheer S, Vasey FB, Nord J. Hypersensitivity Vasculitis with Leukocytoclastic Vasculitis Secondary to Infliximab. Journal of Clinical Gastroenterology. 36(5):411-3, 2003.
  11. Carter JD, Warner E. Tumoral Calcinosis in a patient with Sarcoidosis. Arthritis & Rheumatism. 48(6):1770, 2003.
  12. Carter JD, Valeriano J, Vasey FB. A Case of Crohn’s Disease Worsened by Anakinra. Journal of Clinical Rheumatology. 9(4):275-6, 2003.
  13. Carter JD, Bognar B, Valeriano J, Vasey FB. Refractory neurosarcoidosis: a dramatic response to Infliximab. American Journal of Medicine. 117(4):277-9, 2004.
  14. Carter JD, Valeriano J, Vasey FB. A Prospective, Randomized 9-Month Comparison of Doxycycline vs. Doxycycline and Rifampin in Undifferentiated Spondyloarthropathy – with Special Reference to Chlamydia-Induced Arthritis. Journal of Rheumatology. 31(10):1973-80, 2004.
  15. Lodhi A, Carter JD, Valeriano J, Vasey FB. Can We Classify Psoriatic Arthritis? (editorial). Seminars in Arthritis & Rheumatism. 34(3):571-2, 2004.
  16. Carter JD. Treatment of Relapsing Polychondritis with a Tumor Necrosis Factor Inhibitor. Journal of Rheumatology. 32(7):1413, 2005.
  17. Carter JD, Valeriano J, Vasey FB. Antimicrobials for the Treatment of Chlamydia-Induced Reactive Arthritis. Annals of the Rheumatic Diseases. 64(3):512-3, 2005.
  18. Carter JD, Valeriano J, Vasey FB. Tumor Necrosis Factor Inhibition and VATER Association: A Causal Relationship? Journal of Rheumatology. 33(5):1014-7, 2006.
  19. Cruse LM, Valeriano J, Vasey FB, Carter JD. Prevalence of Evaluation and Treatment of Glucocorticoid-Induced Osteoporosis in Men Hospital. Journal of Clinical Rheumatology. 12(5):221-5, 2006.
  20. Carter JD, Valeriano J, Vasey FB. Hydroxychloroquine as a Treatment for Atrophoderma of Pasini and Pierini. International Journal of Dermatology. 45(10):1255-6, 2006.
  21. Carter JD, Vasey FB, Valeriano J. The Effect of a Low Carbohydrate Diet on Bone Turnover. Osteoporosis International. 17(9):1398-1403, 2006.
  22. Vasey FB, Carter JD. Intestinal Flora and Psoriatic Arthritis. Journal of Rheumatology. 33(10):2099, 2006.
  23. Carter, JD, Espinoza LR. The Interplay of Environment and Host Response in Reactive Arthritis: Can We Intervene? Future Rheumatology. 1(6):717-27, 2006.
  24. Carter, JD. TNF-alpha Inhibition Causing Psoriasis? A More Plausible Explanation Exists. Annals of the Rheumatic Diseases. 65(12):1680, 2006.
  25. Carter JD. Reactive Arthritis: Defined Etiologies, Emerging Pathophysiology, and Elusive Treatment. Infectious Disease Clinics of North America. 20(4):827-47, 2006.
  26. Carter JD, Lodhi A, Nagda SR, Ricca L, Ward C, Traina E, Thompson ZJ, Huang x, Valeriano J, Vasey FB. Determining Rheumatologists’ Accuracy at Assessing Functional Disability in Rheumatoid Arthritis Patients by Using the Health Assessment Questionnaire – Disability Index (HAQ-DI). Journal of Rheumatology. 34(5):958-63, 2007.
  27. Brown NA, Carter JD. Urticarial Vasulitis. Current Rheumatology Reports. 9(4):312-9, 2007.
  28. Carter JD. Functional Disability Determination of the Rheumatoid Arthritis Patient: A Failing System. Touch Briefings, US Musculoskeletal Review. Issue II:26-7, 2007.
  29. McKinley J, Vasey F, McMillen A, Carter J, Brady P. Joint Observations with Lessons for Rheumatologists and Gastroenterologists. Inflammatory Bowel Disease 14(5):730-1, 2008.
  30. Carter JD, Patel S, Sultan FL, Thompson ZJ, Hemstreet M, Sterrett A, Carney G, Murphy N, Huang Y, Valeriano J, Vasey FB. The Recognition and Treatment of Vertebral Fractures in Males with Chronic Obstructive Pulmonary Disease. Respiratory Medicine. (in press)
  31. Carter JD, Gerard HC, Hudson AP. Psoriasiform Lesions Induced by TNF Antagonists: A Skin-Deep Medical Conundrum. Annals of the Rheumatic Diseases (in press)
  32. Baag AA, Vale FL, Carter JD, Rojiani AM. An Elusive Case of Wegener’s Granulomatosis with CNS Involvement: A Neuroimaging Clinicopathologic Correlation. Journal of Neuroimaging (in press)
  33. Shetty A, Marcum C, Glass LF, Carter JD. Successful Treatment of Pemphigus Vulgaris with the TNF-alpha Antagonist Etanercept in 4 Patients. Journal of the American Academy of Dermatology (submitted)
  34. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A Safety Assessment of TNF Antagonists During Pregnancy: A Review of the FDA Database. Journal of Rheumatology. 2009;36(3):635-41.

  35. Ingram S, McKinley JM, Vasey F, Carter JD, Brady PG. Are Inflammatory Bowel Disease and Pouchitis a Reactive Enteropathy to Group D Streptococci (Enterococci)? Inflammatory Bowel Disease 2009;15(11):1609-10.

  36. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano-Marcet J, Snelgrove J, Oszust C, Vasey FB, Hudson AP.  Chlamydiae as Etiologic Agents for Chronic Undifferentiated Spondyloarthropathy. Arthritis & Rheumatism 2009;60(5):1311-1316.

  37. Gerard HC, Whittum-Hudson JA, Carter JD, Hudson AP. Molecular Biology of Infectious Agents in Chronic Arthritis. Rheumatic Disease Clinics of North America 2009;35(1):1-19.

  38. Carter JD, Hudson AP. Reactive Arthritis: Clinical Aspects and Medical Management. Rheumatic Disease Clinics of North America2009;35(1):21-44.

  39. Breglia M, Carter JD. Atypical Insufficiency Fracture of the Tibia Associated with Long-Term Bisphosphonate Therapy. Journal of Clinical Rheumatology 2010;16(2):76-8

  40. Carter JD, Kedar RP, Anderson SR, Osorio AH, Albritton NL, Gnanashanmugam S, Valeriano-Marcet J, Vasey FB, Ricca LR. MRI and Ultrasound Findings in Patients with Gout and Normal Plain Radiographs. Rheumatology (Oxford) 2009;48(11):1442-6.

  41. Carter JD, Hudson AP. Time to Prove the Infective Etiology of Ankylosing Spondylitis and Related Spondyloarthritidies. Arthritis & Rheumatism 2009;60(11):3520-1.

  42. Stanich JA, Carter JD, Whittum-Hudson JA, Hudson AP. Rheumatoid arthritis: disease or syndrome? Open Access Rheumatology: Research and Reviews 2009;1(12).

  43. Gérard HC, Stanich JA, Oszust C, Whittum-Hudson JA, Carter JD, Schumacher HR, Hudson AP.  Functional CCR5 receptor protects arthritis patients from high synovial burden of infecting Chlamydia trachomatis. American Journal of Medical Sciences 2010;340(6):448-51. Aug 31 epub ahead of print.

  44. Gérard HC, Stanich JA, Whittum-Hudson JA, Schumacher HR, Carter JD, Hudson AP. Patients with Chlamydia-Induced Arthritis have Ocular (trachoma), Not Genital, Serovars of C trachomatis in Synovial Tissue. Microbial Pathogenesis 2010;48(2):62-8.

  45. Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, Valeriano J, Stanich JA, Oszust C, Gérard HC, Hudson AP. Combination Antibiotics as a Treatment for Chronic Chlamydia-Induced Reactive Arthritis. Arthritis & Rheumatism 2010;62(5):1298-1307.

  46. Carter JD. Treating Reactive Arthritis:  Insights for the Clinician. Therapeutic Advances in Musculoskeletal Disease 2010;2(1):45-54.

  47. Osting VC, Carter JD. A Safety Assessment of the TNF-antagonists During Pregnancy. Expert Opinion on Drug Safety 2010;9(3):421-9.

  48. Carter JD. Bacterial Agents in Spondyloarthritis: A Destiny from Diversity? Best Practice & Research: Clinical Rheumatology2010;24(5):701-14.

  49. Gerard HC, Whittum-Hudson JA, Carter JD, Hudson AP. The Pathogenic Role of Chlamydia in Spondyloarthritis. Current Opinion in Rheumatology 2010:363-7.

  50. Carter JD, Hudson AP. The Evolving Story of Chlamydia-Induced Reactive Arthritis. Current Opinion in Rheumatology 2010;22(4):424-30.

  51. Carter JD, Hudson AP. Chlamydia-Induced Reactive Arthritis: The Potential for Eradication (Editorial). International Journal of Clinical Rheumatology 2010;5(5):505-8.

  52. Shetty A, Carter JD. Sarcoidosis Mimicking Lymphoma on FDG-PET Imaging. Radiology Case Reports 2011;6(2):1-4.

  53. Sterrett AG, Bateman H, Guthrie J, Rehman A, Osting V, Carter JD, Ricca LR, Valeriano J. Using Simulators to Teach Medical Students, Internal Medicine Residents, and Rheumatology Subspecialty Residents Arthrocentesis. Journal of  Clinical Rheumatology2011;17(3):121-3.

  54. Carter JD, Gerard HC, Whittum-Hudson JA, Hudson AP. Combination antibiotics for the treatment of Chlamydia-induced Reactive Arthritis: is a cure in sight? International Journal of Clinical Rheumatology 2011;6(3):333-45.

  55. Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight? Best Practice & Research: Clinical Rheumatology2011;25:359-74.

  56. Carter JD, Inman RD, Whittum-Hudson JA, Hudson AP. Chlamydia and Chronic Arthritis. Annals of Medicine 2012;44(8):784-92.

  57. Gerard HC, Carter JD, Whittum-Hudson JA, D, Hudson AP. C. trachomatis Is Present And Metabolically Active During The Remitting Phase In Synovial Tissues From Patients With Chronic Chlamydia-Induced Reactive Arthritis. American Journal of Medical Sciences2012 Sept 20 [epub ahead of print].

  58. Carter JD, Zarabadi SA, Ricca LR, McNeil A, Valeriano-Marcet J, Vasey FB, Sebba AI. A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis. Clinical Rheumatology 2012;31(11):1605-10.

  59. Carter JD, Gerard HC, Whittum-Hudson JA, Hudson AP. The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. International Journal of Clinical Rheumatology 2012;7(6):627-40.

  60. Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.  Arthritis Research & Therapy2013;15(1):R25. [Epub ahead of print]

  61. Carter JD, Rehman A, Guthrie JP, Gerard HC, Stanich J, Hudson AP. A Prospective Analysis of the Attack Rate of Chlamydia-Induced Reactive Arthritis and the Effect of CCR5-Delta-32 Mutation. Journal of Rheumatology (in press)

  62. Fischbach KE, Coe B, Radwan M, Gonzalez J, Carter JD, Rumbak MJ. Macrophage Activation Syndrome in a Patient with Adult Stills Disease Following Rituximab: presenting with ‘pseudo-septic shock’. ICU Director (in press)

  63. Carter JD, Patelli M, Anderson SR, Prakash N, Aydelott R, Rodriquez EJ, Bateman H, Sterrett AG, Valeriano J, Ricca LR. An Assessment of Chronic Synovial-Based Inflammation in Gout and its Correlation with Serum Urate Levels. Annals of Rheumatic Diseases (submitted).

     

▲ Back to Top

Published Books or Book Chapters

  1. Carter JD. Methotrexate. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:199-205.
  2. Carter JD. Hydroxychloroquine. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:205-8.
  3. Carter JD. Calcitonin. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:229-33.
  4. Carter JD. Leflunomide. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:210-4.
  5. Carter JD. Etanercept. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:214-20.
  6. Carter JD. Infliximab. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:220-3.
  7. Carter JD. Adalimumab. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:223-6.
  8. Guthrie JP, Carter JD. Reactive Arthritis (a monograph written for an online textbook). British Medical Journal Publishing; London, England. (in press)
  9. Carter JD. Lupus Panniculitis. In Valeriano-Marcet J & Bateman H. Visual Diagnosis: Self Tests on Rheumatology. 2009:52-54.

  10. Carter JD. Pustular Psoriasis and TNF Antagonists. In Valeriano-Marcet J & Bateman H. Visual Diagnosis: Self Tests on Rheumatology. 2009:55-58.

  11. Carter JD. Hypersensitivity Vasculitis. In Valeriano-Marcet J & Bateman H. Visual Diagnosis: Self Tests on Rheumatology. 2009:65-70.59-64.

  12. Carter JD. CNS Manifestations of Wegener’s Granulomatosis. In Valeriano-Marcet J & Bateman H. Visual Diagnosis: Self Tests on Rheumatology. 2009:71-76.

  13. Carter JD. Neurosarcoidosis. In Valeriano-Marcet J & Bateman H. Visual Diagnosis: Self Tests on Rheumatology. 2009:77-82.

  14. Carter JDReactive Arthritis. In Fitzpatrick’s Dermatology in General Medicine (8th Edition). McGraw Hill Publishing. Philadelphia, PA. 2012; Chapter 20:243-52.

  15. Carter JD, Hudson AP. Spondyloarthritis – Reactive Arthritis. In Encyclopedia of Medical Immunology (MacKay, Ian, Rose, Noel R, Eds). Springer Science Business Media. Berlin, Germany. In press.

  16. Carter JD, Oikonomopoulis I. Acute Rheumatic Fever. In inPractice Rheumatology (Borenstein D, Editor). inPractice Resources, LLC. In press.

  17. Carter JDReactive Arthritis. In inPractice Rheumatology (Borenstein D, Editor). inPractice Resources, LLC. In press.

  18. Carter JD, Taurog JD. Psoriatic Arthritis. In Harrison’s Principles of Internal Medicine (19th Edition). McGraw Hill Publishing, Philadelphia, PA. In press.

  19. Carter JD, Taurog JD. Reactive Arthritis. In Harrison’s Principles of Internal Medicine (19th Edition). McGraw Hill Publishing, Philadelphia, PA. In press.

▲ Back to Top

Abstracts Presented/Published

  1. Carter JD, Mills CR, Valeriano J, Kanik KS and Vasey FB: Preliminary 6 month results of a prospective comparison of doxycycline vs. doxycycline and rifampin in undifferentiated spondyloarthritis. Arthritis and Rheumatism. 44(9 supplement):S92(235),2001. American College of Rheumatology National Convention; San Francisco, CA; October 22, 2001. University of South Florida Research Day; Tampa, FL; February 24, 2002.
  2. Valeriano-Marcet J, Johnson T, Lowenstein M, Dacchille B, Stephenson A, Carter JD, Vasey FB: Osteoporosis Risk Assesment Tool (ORAT) Assists Clinicians in Selecting Postmenopausal Women for DXA Testing. ASBMR 25th Annual Meeting, September 19-23, 2003.
  3. Kirzhner I, Howell T, Rhee D, Warman M, Sandy J, Carter JD, Plaas A. Disulfide Bonded Multimers of Lubricin in Normal Synovial Fluid – Synthesis and Assembly by Synovial Lining Cells. Cartilage Innovation Summit; Cleveland Clinic, May 2005.
  4. Lodhi A, Valeriano J, Vasey FB, Carter JD. Rheumatologists’ Ability to Predict Functional Disability in Rheumatoid Arthritis Patients by Using the Health Assessment Questionnaire (HAQ). American College of Rheumatology National Convention, San Diego, CA; November 11-17, 2005. University of South Florida Research Day, Tampa, FL; February 23, 2006
  5. Brown NA, Vasey FB, Carter JD. TNF-alpha Antagonists and the Induction of Autoantibodies. University of South Florida Research Day, Tampa, FL; February 23, 2007. Rheumatology on the Beach, Destin, FL; March 28, 2007.
  6. Guthrie JP, Oszust C, Hudson AP, Carter JD. CCR-5 Delta 32 Mutation and its Relationship to the Development of Chlamydia-Induced Reactive Arthritis. Rheumatology on the Beach, Destin, FL; March 28, 2007.
  7. Carter JD, Espinoza LR, Inman RD, Seleznick M, Sneed K, Ricca L, Valeriano J, Vasey FB, Oszust C, Snelgrove J, Hudson AP. An Evaluation of the Utility of PBMC PCR Testing for Chlamydia in Subjects with Suspected Chronic Chlamydia-Induced Reactive Arthritis. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S540. (Accepted as a Presentation at Concurrent Session).
  8. Carter JD, Espinoza LR, Inman RD, Seleznick M, Sneed K, Ricca L, Valeriano J, Vasey FB, Oszust C, Snelgrove J, Gerard H, Hudson AP. A Comparison of the Phenotypic Manifestations of Chlamydia trachomatis vs. Chlamydophila pneumoniae-Induced Reactive Arthritis. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S541. (Accepted as a Presentation at Concurrent Session).
  9. Carter JD, Ladhani A, Ricca L, Valeriano J, Vasey FB. A Safety Assessment of the TNF Antagonists During Pregnancy: A Review of the FDA Database. An Evaluation of Predictive Factors. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S286. (Accepted as a Presentation at Plenary Session I).
  10. Hudson AP, Oszust C, Guthrie JP, Whittum-Hudson JA, Snelgrove J, Carter JD, Schumacher HR, Gerard HC. Functional CCR5 Receptor Protects From High Synovial Chlamydia trachomatis Burden but Differentially Protects Against Induction of Inflammatory Arthritis in ReA and UO Patients. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S619.
  11. Hudson AP, Schumacher HR, Whittum-Hudson JA, Carter JD, Gerard HC. Patients Infected with Chlamydia Trachomatis Frequently Have Ocular, Not Genital, Serovars of the Organism in the Synovial Tissue. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S619.
  12. Beg H, Carter JD, Vasey FB, Valeriano J. Long-Term Follow Up of Combination Antimicrobial Therapy for Chlamydia-Induced ReA. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007.

▲ Back to Top